Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

August 01, 1989; Volume 250,Issue 2
  • You have access
    Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
    J B Watkins
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 421-427;
  • You have access
    Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
    J G Drewett, R J Ziegler, G R Marchand and G J Trachte
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 428-432;
  • You have access
    Adenosine-angiotensin II interactions. Part I. Role of adenosine in regulating angiotensin II-induced potentiation of noradrenergic neurotransmission and angiotensin II-induced vasoconstriction.
    B J Holycross and E K Jackson
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 433-441;
  • You have access
    Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
    B J Holycross, P Li and E K Jackson
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 442-453;
  • You have access
    Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
    D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;
  • You have access
    Nonneurogenic relaxation to field stimulation in coronary arteries.
    S Kalsner and M Quillan
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 461-469;
  • You have access
    Role of purines and xanthine oxidase in reperfusion injury in perfused rat liver.
    Z Zhong, J J Lemasters and R G Thurman
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 470-475;
  • You have access
    A role for histamine and H2-receptors in opioid antinociception.
    K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;
  • You have access
    Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
    S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 485-491;
  • You have access
    Analysis of the presence of postjunctional alpha-2 adrenoceptors in the rat anococcygeus muscle.
    M V Ramagopal and H J Leighton
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 492-499;
  • You have access
    Studies on the cardiovascular actions of central histamine H1 and H2 receptors.
    J J Poulakos and S B Gertner
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 500-507;
  • You have access
    Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    B Y Ho and A E Takemori
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 508-514;
  • You have access
    Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
    P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;
  • You have access
    Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
    J P Hieble, J G Duesler and R N Daly
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 523-528;
  • You have access
    Vanadate stimulates the N-ethylmaleimide-sensitive adenosine triphosphatase in rat nephron.
    S Sabatini and N A Kurtzman
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 529-533;
  • You have access
    Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
    R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;
  • You have access
    Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development.
    W Balduini and L G Costa
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 541-547;
  • You have access
    Cellular mechanisms of endothelin in rabbit aorta.
    E H Ohlstein, S Horohonich and D W Hay
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 548-555;
  • You have access
    Role of brain tyrosine availability in mediating differences in ethanol sensitivity in long-sleep and short-sleep mice.
    T A French, K L Clay and N Weiner
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 556-564;
  • You have access
    Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.
    M McKinney, D Anderson, C Forray and E E el-Fakahany
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 565-572;
  • You have access
    Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    D D Flynn and D C Mash
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 573-581;
  • You have access
    Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation.
    A G King, K S Landreth and D Wierda
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 582-590;
  • You have access
    BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
    J M Post, J M Smith and A W Jones
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 591-597;
  • You have access
    An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
    R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;
  • You have access
    Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
    D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;
  • You have access
    Regional O2 consumption and coronary flow during beta adrenoceptor stimulation in reperfused canine myocardium.
    B A Acad and H R Weiss
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 611-616;
  • You have access
    Muscarinic modulation of endogenous acetylcholine release in rat neostriatal slices.
    M H Weiler
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 617-623;
  • You have access
    SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
    E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;
  • You have access
    Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
    S X Wang, T A Sutfin, C Bäärnhielm and C G Regårdh
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 632-636;
  • You have access
    Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
    M Yoshioka
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 637-641;
  • You have access
    Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
    E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;
  • You have access
    Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors.
    M Raiteri, G Bonanno and E Fedele
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 648-653;
  • You have access
    Effect of S-8666 on urinary Ca++ excretion in rats.
    T Shimizu, K Miyata and M Nakamura
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 654-658;
  • You have access
    Additive diuretic effect of S-8666 during furosemide-induced diuresis in rats.
    T Shimizu, T Itoh and M Nakamura
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 659-666;
  • You have access
    Hepatoprotective effects of cystathionine against acetaminophen-induced necrosis.
    Y Kitamura, Y Kamisaki and T Itoh
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 667-671;
  • You have access
    Adrenergic agonists and the Na+-K+-adenosine triphosphatase from rabbit proximal tubules and their basolateral membranes.
    R A Podevin and A Parini
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 672-677;
  • You have access
    Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
    R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;
  • You have access
    Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
    L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;
  • You have access
    Transport of methotrexate by the in vitro isolated rabbit proximal tubule.
    K Besseghir, D Mosig and F Roch-Ramel
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 688-695;
  • You have access
    Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
    K M Dewar, B Montreuil, L Grondin and T A Reader
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 696-706;
  • You have access
    Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system.
    M Frenken and A J Kaumann
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 707-713;
  • You have access
    Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis.
    K G Mugridge, D Donati, S Silvestri and L Parente
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 714-720;
  • You have access
    Skeletal muscle Na,K-pump concentration in children and its relationship to cardiac glycoside distribution.
    K Kjeldsen and P Grøn
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 721-725;
  • You have access
    Differential effects of somatostatin on atrial and ventricular contractile responses in guinea pig heart: influence of pretreatment with islet-activating protein.
    M Endou, Y Hattori, H Nakaya and M Kanno
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 726-733;
  • You have access
    Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
    A Horiuchi, K Iwatsuki, H Yonekura and S Chiba
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 734-739;
  • You have access
    Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig.
    I Macquin-Mavier, M Levame, N Istin and A Harf
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 740-745;
  • You have access
    Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
    M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;
  • You have access
    Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture.
    D M Hartley and D W Choi
    Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 752-758;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 250, Issue 2
1 Aug 1989
  • Table of Contents
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Smoking Could Worsen COVID-19 Outcome
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Potential Clinical Uses of CBG
  • Nose-to-Brain Delivery
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics